HALO logo
halo search icon
Harrow, Inc.

US$30.86

Price Change Indicator
0.18 (0.587%)
Harrow, Inc.
HROW · NAS

Harrow, Inc.

Start Trading HROW for Free

US$30.86

Price Arrow0.18 (0.587%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapEMA 125 BreakdownHALO AllHALO Capital EfficiencyHALO Consensus ValueRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Harrow, Inc. Overview

HROW Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About HROW

icon
icon

Telephone

1.615.733.4730

icon

Address

Suite 200, 1A Burton Hills Boulevard, Nashville, TN 37215

Description

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

HROW Price Chart

Key Stats

Market Cap

US$1.14B

PE

908.10

EV/EBITDA

34.3

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 25.21 - 54.85

Trade Value (12mth)

US$6,455,790.00

1 week

-1.7%

1 month

-22.23%

YTD

-38.53%

1 year

14.78%

All time high

160.00

Key Fundamentals

EPS 3 yr Growth

-72.70%

EBITDA Margin

21.10%

Operating Cashflow

$44m

Free Cash Flow Return

14.60%

ROIC

-1.70%

Interest Coverage

2.40

Quick Ratio

2.10

Other Data

Shares Outstanding (Fully Diluted)

37m

HALO Sector

Healthcare

Next Company Report Date

08-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

HROW Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
12 May 26
28 March 26

HROW Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.75-0.49-0.14locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.75-0.49-0.14locklocklock
Growth
 %locklocklocklock-45.934.571.5locklocklock
PE
 Xlocklocklocklock424.3123.8908.1locklocklock
EV/EBITDA
 Xlocklocklocklock3659.834.3locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Harrow, Inc. (HROW:NAS)?
Halo FAQ
The current share price of Harrow, Inc. (HROW:NAS) is USD$30.86.
What is the 52-week high share price for Harrow, Inc. (HROW:NAS)?
Halo FAQ
The 52-week high share price for Harrow, Inc. (HROW:NAS) is USD$54.85.
What is the 52-week low share price for Harrow, Inc. (HROW:NAS)?
Halo FAQ
The 52-week low share price for Harrow, Inc. (HROW:NAS) is USD$25.21.
What is the dividend yield for Harrow, Inc. (HROW:NAS)?
Halo FAQ
Harrow, Inc. (HROW:NAS) does not pay a dividend.
What was Harrow, Inc. (HROW:NAS) last dividend payment?
Halo FAQ
Harrow, Inc. (HROW:NAS) does not pay a dividend.
What is the franking level for Harrow, Inc. (HROW:NAS)?
Halo FAQ
Harrow, Inc. (HROW:NAS) has a franking level of 0.00%.
In which sector is Harrow, Inc. (HROW:NAS) classified?
Halo FAQ
Harrow, Inc. (HROW:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Harrow, Inc. (HROW:NAS)?
Halo FAQ
The current P/E ratio for Harrow, Inc. (HROW:NAS) is 908.10.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial